Effect of Cefixime and Cefdinir, Oral Cephalosporins, on Cytochrome P450 Activities in Human Hepatic Microsomes
The effects of two kinds of oral cephalosporins, cefixime and cefdinir, on cytochrome P450 (CYP) activities in human hepatic microsomes were investigated. Both cefixime and cefdinir at 2 mM concentration neither inhibited nor stimulated CYP1A1/2-mediated 7-ethoxyresorufin O-deethylation, CYP2A6-mediated coumarin 7-hydroxylation, CYP2B6-mediated 7-benzyloxyresorufin O-debenzylation, CYP2C8/9-mediated tolbutamide methylhydroxylation, CYP2C19-mediated S-mephenytoin 4-hydroxylation, CYP2D6-mediated bufuralol 1-hydroxylation, CYP2E1-mediated chlorzoxazone 6-hydroxylation, CYP3A4-mediated nifedipine oxidation, or CYP3A4-mediated testosterone 6b b-hydroxylation. The free fractions of cefixime and cefdinir in the incubation mixture, which were measured by ultracentrifugation, were 86.1-93.8% and 94.1-97.8%, respectively. These results suggest that both cefixime and cefdinir would not cause clinically significant interactions with other drugs, which are metabolized by CYPs, via the inhibition of metabolism.
previously. 15, 16) The incubation mixture consisted of human microsomes, 2.5 mM NADP ϩ , 25 mM glucose-6-phosphate, 10 mM magnesium chloride, 2 units of glucose-6-phosphate dehydrogenase, 100 mM potassium phosphate buffer (pH 7.4), 0.1 mM EDTA, and 0.01 ml of 200 mM sodium bicarbonate or 100 mM cefixime or cefdinir dissolved in 200 mM sodium bicarbonate in a final volume of 0.5 ml. 15, 16) The microsomal protein concentration in the mixture was 0.2 (for 7-ethoxyresorufin O-deethylation, coumarin 7-hydroxylation, and 7-benzyloxyresorufin O-debenzylation), 0.5 (for tolbutamide methylhydroxylation, nifedipine oxidation, and testosterone 6b-hydroxylation), or 1 mg/ml (for S-mephenytoin 4Ј-hydroxylation, bufuralol 1Ј-hydroxylation, and chlorzoxazone 6-hydroxylation). Concentrations of 7-ethoxyresorufin, coumarin, 7-benzyloxyresorufin, tolbutamide, Smephenytoin, bufuralol, chlorzoxazone, nifedipine, and testosterone were 0.5, 2, 1.5, 400, 100, 20, 100, 30, and 150 mM, respectively; which are around the expected K m . 15, 16) Because cefdinir interfered with the assay of methylhydroxytolbutamide by the methods described previously, 15, 16) the effect of cefdinir on the methylhydroxytolbutamide formation was determined as follows. Briefly, after the reaction was terminated by the addition of 1 M HCl, 50 ml of internal standard (20 mg/ml sodium phenobarbital) and 3 ml of ethylacetate/hexane (1 : 1) were added, and the mixtures were shaken for 10 min and centrifuged at 1900 g for 5 min. The organic phase (2.5 ml) obtained was evaporated under nitrogen, and the residue was dissolved in 200 ml of methanol/5 mM potassium dihydrogenphosphate (42 : 58), and 80 ml was applied to HPLC. HPLC analyses were performed using an Inertsil ODS-3 (5 mm, 150ϫ4.6 mm I.D., GL Sciences, Tokyo, Japan) as a column and a TSK-guardgel ODS-80Ts (15ϫ3.2 mm I.D., Tosoh Tokyo, Japan) as a guard-column, and the column temperature was maintained at 40°C. The mobile phase was methanol/5 mM potassium dihydrogenphosphate 
Determination of Free Fraction in Incubation Mixture
The incubation mixture consisted of human microsomes (0.2-1.0 mg/ml), 2 mM cefixime or cefdinir, 100 mM potassium phosphate buffer (pH 7.4), and 0.1 mM EDTA in a final volume of 0.5 ml. 15 ) After a 5-min incubation at 37°C, the mixture was centrifuged at 105000 g for 60 min at 4°C, 15) and the concentration of cefixime or cefdinir in the supernatant was measured by HPLC with an analytical column TSKgel ODS-80T M (150ϫ4.6 mm I.D., Tosoh Co., Tokyo, Japan). The column temperature was set at 40°C. The elution was conducted with 30% (for cefixime) or 20% (for cefdinir) methanol in 20 mM phosphate buffer (pH 2.5) at a flow rate of 1 ml/min, and detection was by UV absorbance at 295 nm.
RESULTS AND DISCUSSION
The inhibitory effects of cefixime and cefdinir on metabolic activities in human hepatic microsomes are summarized in Table 1 . 7-Ethoxyresorufin O-deethylase, coumarin 7-hydroxylase, 7-benzyloxyresorufin O-debenzylase, tolbutamide methylhydroxylase, S-mephenytoin 4Ј-hydroxylase, bufuralol 1Ј-hydroxylase, chlorzoxazone 6-hydroxylase, nifedipine oxidase, and testosterone 6b-hydroxylase activities in the presence of cefixime or cefdinir at a concentration of 2 mM were 82.0-112.1% of the control, indicating that these cephalosporins had neither inhibitory nor stimulatory effects.
The free fractions of cefixime and cefdinir in the incubation mixture containing 0.2-1 mg/ml of microsomal protein were 86.1-93.8% and 94.1-97.8%, respectively, and the values were constant through the protein concentrations (Table 2 ). These results indicate that the protein binding of cefixime and cefdinir in the incubation mixture are of minor importance.
When the substrate concentration is much lower than the K m value, the degree of inhibition (R) can be expressed by 98 Vol. 27, No. 1 where I u and K i are the unbound concentration of the inhibitor and the inhibition constant, respectively. Additionally, when the absorption rate is maximum, the maximum inflow concentration of the inhibitor into liver (I in,max ) can be expressed as,
where I max , k a , D, Q H , and F a represent the maximum plasma concentration of the inhibitor in the circulation, absorption rate constant, dose, and hepatic blood flow, and the fraction absorbed from the gastrointestinal tract into the portal vein, respectively. After an oral dosing of 200 mg cefixime and cefdinir in healthy volunteers, the peak plasma concentrations (I max ) are 1.95 and 1.74 mg/ml, (4.3, 4.4 mM) respectively. 19, 20) Additionally, approximately 21.2-27.6% and 25.9-33.3%, respectively, of dosing is excreted in urine unchanged, and no metabolites with antibacterial activity are detected in the serum or urine. 19, 20) I in,max for cefixime and cefdinir are calculated using k a ϭ0.1 min
Ϫ1
, Q H ϭ1610 ml/ min, F a ϭ1 to avoid false-negative predictions, to be 32 and 36 mM, respectively. In addition, protein binding of cefixime and cefdinir in human serum is reported to be 70.2-72.0% and 73.1%, respectively. 21, 22) Therefore, the predicted free fractions of I in,max are much lower than the concentration investigated in this study (2 mM), suggesting that both cefixime and cefdinir might not affect the pharmacokinetics and metabolism of drugs metabolized by CYP1A1/2, CYP2A6, CYP2B6, CYP2C8/9, CYP2C19, CYP2D6, CYP2E1, or CYP3A4.
In conclusion, the present study suggests that both cefixime and cefdinir would not cause clinically significant interactions with other drugs, which are metabolized by CYPs, via the inhibition of metabolism.
